Skilled iv therapy clinicians' product evaluation of open-ended versus closed-ended valve PICC lines: a cost savings clinical report.
The IV therapy clinician team at Florida Hospital has become active product selectors of IV therapy materials for the institution. It is recognized for its expertise, experience, and knowledge in IV therapy. As end users of many IV therapy products, members are well-qualified to act as principal product selectors of these patient care items. These clinicians identified costly problems with the performance of a conventional open-ended peripherally inserted central catheter (PICC) product being used. A market search for a better product was done and the Bard Groshong closed-ended valve PICC (Bard Access Systems, Inc., Salt Lake City, UT) was selected. These PICCs were used for a 6-week trial period. The 58 inserted Groshong closed-ended valve PICCs were compared with the last 58 open-ended PICCs inserted. Greater quality assessment was apparent in its performance. A substantial cost savings of 21% also was achieved by using the Groshong closed-ended valve PICCs. A clinical report comparing these two products was presented to the value analysis committee. The validated superior performance of the Groshong closed-ended valve PICC with the cost savings for the 6-week trial period won the committee's approval and the change was made to the Groshong closed-ended valve PICC.
Hinson
E K
EK
Blough
L D
LD
D002405:Catheterization, Central Venous / Q000295:instrumentation*; D002406:Catheterization, Peripheral / Q000295:instrumentation*; D002408:Catheters, Indwelling / Q000191:economics* / Q000592:standards*; D017046:Cost Savings; D003362:Cost-Benefit Analysis; D006801:Humans; D011785:Quality Assurance, Health Care